CPA: EU Must Reject Aurobindo’s $5.5 Billion Zentiva Takeover

CPA: EU Must Reject Aurobindo’s $5.5 Billion Zentiva Takeover

Aurobindo Pharma’s proposed $5.5 billion acquisition of Prague-based Zentiva poses an unacceptable risk to Europe’s and America’s pharmaceutical security. CPA is calling on the European Union (EU), including Czech authorities and European Commission competition regulators, to reject the transaction.

New Report Shows China’s Plan to Dominate the World Space Market, Supported by U.S. Investors

New Report Shows China’s Plan to Dominate the World Space Market, Supported by U.S. Investors

The study details how Beijing is pursuing a program of “space sector capture” to penetrate and control the space sectors of more than 120 countries through agreements with ostensibly private Chinese companies that, in effect, act as fronts for the People’s Liberation Army (PLA).